Further studies should confirm IRF3 and IRF7 genetic polymorphisms as risk factors for UTI recurrence in different populations. Additional studies should evaluate benefits of suppressing IRF7 expression by administering liposomal IRF7 siRNA on UTI recurrence. Here, IRF7 is linked to bacterial urinary tract infection.